Syarikat: Novo Nordisk

Novo Nordisk is a global healthcare company headquartered in Denmark, specializing in diabetes care and other chronic diseases. In Malaysia, it is committed to improving the lives of patients through innovative therapies and sustainable practices. The company focuses on research, development, and the provision of high-quality medications. With a robust presence in the Malaysian healthcare landscape, Novo Nordisk aims to enhance disease management and patient outcomes, leveraging its expertise in diabetes and hormone replacement therapies. Its dedication to public health and community engagement underlines its role as a leader in the pharmaceutical industry.